Pancreatic Cancer Treatment Breakthrough: Drug Combination Doubles One-Year Survival
A phase II trial shows elraglusib combined with chemotherapy doubles one-year survival for pancreatic cancer patients and reduces death risk by 38%, offering new hope for a challenging disease.
Key Points
- Elraglusib plus chemotherapy doubles one-year survival for pancreatic cancer
- Treatment reduces risk of death by 38% in phase II trial
- Offers new hope for patients with historically poor prognosis
Full Details
A phase II randomized trial published in Nature Medicine has demonstrated that elraglusib combined with chemotherapy doubles one-year survival rates for patients with pancreatic cancer and reduces the risk of death by 38%. The study, led by Professor Devalingam Mahalingam of Northwestern University Feinberg School of Medicine, represents a significant advancement in treating one of the most challenging solid tumors. Pancreatic cancer has historically had poor prognosis, with limited treatment options and low survival rates. The trial results provide cautious optimism for patients, as the drug combination showed meaningful improvements in survival outcomes. Professor Mahalingam emphasized that while pancreatic cancer remains difficult to treat, these findings represent important progress that could change patient outcomes.
Why It Matters
This breakthrough could significantly change treatment paradigms for pancreatic cancer, potentially improving survival rates for a disease with historically limited options.
Get stories like this delivered daily
AI-curated news, personalized to your interests. Zero noise.
Start 7-Day Free Trial →More in Global News
US singer D4vd charged with murder stemming from death of missing teenage girl
Prosecutors say the singer, real name David Anthony Burke, could face life in prison due to the nature of the case.
Ukrainian drone attack hits Russia’s Tuapse port
Plumes of black smoke were seen after Ukrainian drones targeted Russia’s Black Sea port of Tuapse.
Iranian Envoy Summoned After Revolutionary Guards Fire On Indian Ships
The ships -- Indian-flagged cargo vessels - were fired on in the Strait of Hormuz on April 18. The incident occurred due to a communication gap between the Iranian government and the local unit of the Revolutionary Guard, sources said.
‘Israel never talked me into the war with Iran,’ Trump says
President Donald Trump posted on Truth Social that Israel never talked him into a war with Iran, pushing back against news reports and right-wing commentators who suggested Israeli Prime Minister Benjamin Netanyahu influenced his decisions. He wrote that the October 7th attack reinforced his lifelong opinion that Iran can never have a nuclear weapon. Trump also claimed that "the results in Iran will be amazing" and suggested that if Iran's new leaders are "smart," the country could have a great